Literature DB >> 1520323

Molecular cloning of nucleobindin, a novel DNA-binding protein that contains both a signal peptide and a leucine zipper structure.

K Miura1, K Titani, Y Kurosawa, Y Kanai.   

Abstract

We have previously reported that KML1-7 cells cloned from a lupus-prone MRL/l mouse produced a soluble factor that preferentially expanded anti-DNA antibody production across the H-2 barrier. We purified this factor, a 55 kD protein that we termed nucleobindin (Nuc), and obtained its cDNA clone. Although the gene for Nuc encodes a signal peptide and, in fact, Nuc was identified as a secreted protein, Nuc had a DNA-binding property. The putative polypeptide predicted from the cDNA sequence featured a signal peptide, a leucine zipper structure and a basic amino acid-rich region. The DNA-binding property of Nuc was destroyed by deletion of either the leucine zipper structure or the basic amino acid-rich region. The amino acid sequences of Nuc are highly conserved between mouse and human. We discuss the possible role of Nuc in autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520323     DOI: 10.1016/s0006-291x(05)81503-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  Galpha i3 binding to calnuc on Golgi membranes in living cells monitored by fluorescence resonance energy transfer of green fluorescent protein fusion proteins.

Authors:  T S Weiss; C E Chamberlain; T Takeda; P Lin; K M Hahn; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Calnuc, an EF-hand Ca(2+) binding protein, specifically interacts with the C-terminal alpha5-helix of G(alpha)i3.

Authors:  P Lin; T Fischer; T Weiss; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Islet β-cell-produced NUCB2/nesfatin-1 maintains insulin secretion and glycemia along with suppressing UCP-2 in β-cells.

Authors:  Yifei Yang; Boyang Zhang; Masanori Nakata; Jun Nakae; Masatomo Mori; Toshihiko Yada
Journal:  J Physiol Sci       Date:  2019-06-21       Impact factor: 2.781

4.  Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein.

Authors:  B A Ballif; N V Mincek; J T Barratt; M L Wilson; D L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

5.  Nucleobindin 1 is a calcium-regulated guanine nucleotide dissociation inhibitor of G{alpha}i1.

Authors:  Neeraj Kapoor; Ruchi Gupta; Santosh T Menon; Ewa Folta-Stogniew; Daniel P Raleigh; Thomas P Sakmar
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

6.  Fetal regional brain protein signature in FASD rat model.

Authors:  Katie L Davis-Anderson; Hendrik Wesseling; Lara M Siebert; Emilie R Lunde-Young; Vishal D Naik; Hanno Steen; Jayanth Ramadoss
Journal:  Reprod Toxicol       Date:  2018-02-01       Impact factor: 3.143

7.  High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer.

Authors:  Hongtuan Zhang; Can Qi; Andi Wang; Liang Li; Yong Xu
Journal:  Tumour Biol       Date:  2013-10-04

8.  Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats.

Authors:  Tobias Inhoff; Andreas Stengel; Lisa Peter; Miriam Goebel; Yvette Taché; Norbert Bannert; Bertram Wiedenmann; Burghard F Klapp; Hubert Mönnikes; Peter Kobelt
Journal:  Peptides       Date:  2009-12-02       Impact factor: 3.750

9.  Analysis of COPII Vesicles Indicates a Role for the Emp47-Ssp120 Complex in Transport of Cell Surface Glycoproteins.

Authors:  Neil G Margulis; Joshua D Wilson; Christine M Bentivoglio; Nripesh Dhungel; Aaron D Gitler; Charles Barlowe
Journal:  Traffic       Date:  2016-01-10       Impact factor: 6.215

10.  Modulation of nucleobindin-1 and nucleobindin-2 by caspases.

Authors:  C Alexander Valencia; Steven W Cotten; Jinzhu Duan; Rihe Liu
Journal:  FEBS Lett       Date:  2007-12-26       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.